Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04868708
Status:
COMPLETED
Last Update Posted:
2024-04-25
First Post:
2021-04-05
Brief Title:
A Study of AK104 an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody in Recurrent or Metastatic Cervical Cancer
Sponsor:
Akeso
Organization:
Akeso
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-05
First Submit QC Date:
April 30 2021
Study First Post Date:
2021-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-23
Last Update Post Date:
2024-04-25
Last Update Post Date Type:
ACTUAL